| 000 | 01116 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250511172249.0 | ||
| 264 | 0 | _c19760226 | |
| 008 | 197602s 0 0 eng d | ||
| 022 | _a0024-3205 | ||
| 024 | 7 |
_a10.1016/0024-3205(75)90145-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJacquet, Y F | |
| 245 | 0 | 0 |
_aMorphine analgesia: 2-way cross tolerance between systemic and intracerebral (periaqueductal gray) administrations. _h[electronic resource] |
| 260 |
_bLife sciences _cOct 1975 |
||
| 300 |
_a1321-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAnalgesia |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCerebral Aqueduct _xdrug effects |
| 650 | 0 | 4 |
_aCerebral Ventricles _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aInjections, Intraventricular |
| 650 | 0 | 4 |
_aMorphine _xadministration & dosage |
| 650 | 0 | 4 | _aRats |
| 700 | 1 | _aLajtha, A | |
| 773 | 0 |
_tLife sciences _gvol. 17 _gno. 8 _gp. 1321-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0024-3205(75)90145-9 _zAvailable from publisher's website |
| 999 |
_c1202664 _d1202664 |
||